Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$33.58 - $41.2 $23,338 - $28,634
-695 Closed
0 $0
Q4 2022

May 09, 2023

SELL
$37.12 - $46.52 $25,612 - $32,098
-690 Reduced 49.82%
695 $26,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $20,133 - $26,811
551 Added 66.07%
1,385 $61,000
Q2 2022

Aug 10, 2022

BUY
$31.71 - $43.0 $26,446 - $35,862
834 New
834 $31,000
Q3 2019

Nov 12, 2019

SELL
$59.06 - $72.15 $9,154 - $11,183
-155 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$62.09 - $86.14 $2,607 - $3,617
42 Added 37.17%
155 $10,000
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $5,979 - $9,172
113 New
113 $9,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.43B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.